Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2002;87:507-509; doi:10.1136/heart.87.6.507
Copyright © 2002 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2002;87:507-509
© 2002 by Heart

EDITORIAL

Myocardial dysfunction in sepsis: no role for NO?

E Belcher, J Mitchell, T Evans

Unit of Critical Care, Imperial College School of Medicine, Royal Brompton Hospital, London SW3 6NP, UK

Correspondence to:
Correspondence to:
Professor TW Evans, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK;
t.evans@rbh.nthames.nhs.uk


The effects of nitric oxide on myocardial function in clinical sepsis are unclear, with studies in experimental models suggesting both beneficial and deleterious effects

Keywords: sepsis; myocardial dysfunction; nitric oxide

Abbreviations: EDPVR, end diastolic pressure; volume relationship; ESPVR, end systolic pressure-volume relationship; LVEDV, left ventricular end diastolic volume; MLA, monophosphoryl lipid A; NO, nitric oxide; NOS, nitric oxide synthase; SIRS, systemic inflammatory response syndrome; SVR, systemic vascular resistance

Sepsis and its sequelae1 represent an important cause of mortality among the critically ill, particularly if cardiovascular dysfunction ensues. In these circumstances, refractory hypotension develops leading to multiple organ failure, and some 50% of such cases fail to survive.2 Although sepsis is defined as the systemic response to infection, less than 50% of patients with septic shock have positive blood cultures.3 Indeed, the clinical manifestations of sepsis may be seen in association with a variety of non-infective insults including major trauma, burns, pancreatitis, rhabdomyolysis, and surgery necessitating cardiopulmonary bypass, and are then termed the systemic inflammatory response syndrome (SIRS).

MYOCARDIAL DYSFUNCTION IN SEPSIS

Traditionally, descriptions of septic shock defined an early, hyperdynamic phase, with warm peripheries, low systemic vascular resistance (SVR), and high cardiac output. In non-survivors the "warm" phase was thought to progress to a hypodynamic or "cold" phase in which cool peripheries, increased SVR, and low cardiac output were the dominant clinical . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hunter, J. D., Doddi, M. (2009). Sepsis and the heart. Br J Anaesth 0: aep339v1-aep339 [Abstract] [Full Text]  
  • Hauser, B., Bracht, H., Matejovic, M., Radermacher, P., Venkatesh, B. (2005). Nitric Oxide Synthase Inhibition in Sepsis? Lessons Learned from Large-Animal Studies. Anesth. Analg. 101: 488-498 [Abstract] [Full Text]  
  • Subla, M. R., Khan, S. A., Behl, D., Peters, S. G. (2005). Sepsis and Myocardial Depression in a Young Woman. Mayo Clin Proc. 80: 810-814 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.